Company · CIK 1231457
GENELUX Corp
| CIK | 1231457 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | CA |
| Listed | GNLX (Nasdaq) |
| First annual or quarterly report | 2023-03-29 |
Offerings
3 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-276847 | 2024-02-02 | 2026-03-19 | 8 | |
| 333-272966 | 2023-06-28 | 2023-07-03 | 2 | |
| 333-265828 | 2022-06-24 | 2023-01-26 | 9 |
Filings
20| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-03-19 | 424B5Shelf takedown | 333-276847 | 0001493152-26-011696 |
| 2026-01-08 | 424B5Shelf takedown | 333-276847 | 0001493152-26-000986 |
| 2026-01-07 | 424B5Shelf takedown | 333-276847 | 0001493152-26-000825 |
| 2025-03-25 | 424B5Shelf takedown | 333-276847 | 0001641172-25-000644 |
| 2024-05-24 | 424B5Shelf takedown | 333-276847 | 0001493152-24-021410 |
| 2024-05-23 | 424B5Shelf takedown | 333-276847 | 0001493152-24-021168 |
| 2024-02-13 | EFFECTDeclared effective | 333-276847 | 9999999995-24-000429 |
| 2024-02-02 | S-3Shelf registered | 333-276847 | 0001493152-24-004774 |
| 2023-07-03 | EFFECTDeclared effective | 333-272966 | 9999999995-23-001975 |
| 2023-06-28 | S-1Registration filed | 333-272966 | 0001493152-23-022665 |
| 2023-01-26 | 424B4Final prospectus | 333-265828 | 0001193125-23-016372 |
| 2023-01-25 | EFFECTDeclared effective | 333-265828 | 9999999995-23-000180 |
| 2023-01-10 | S-1/AAmendment | 333-265828 | 0001193125-23-005002 |
| 2022-12-23 | S-1/AAmendment | 333-265828 | 0001193125-22-311821 |
| 2022-11-04 | S-1/AAmendment | 333-265828 | 0001193125-22-277807 |
| 2022-10-13 | S-1/AAmendment | 333-265828 | 0001193125-22-262056 |
| 2022-09-19 | S-1/AAmendment | 333-265828 | 0001193125-22-246569 |
| 2022-08-29 | S-1/AAmendment | 333-265828 | 0001193125-22-232732 |
| 2022-06-24 | S-1Registration filed | 333-265828 | 0001193125-22-181565 |
| 2021-05-07 | DRSDraft made public | 377-04813 | 0000950123-21-005600 |